Clinical Trial Update: Evaluation of Single Dosing With Two F/TAF Tablets Among Healthy Volunteers [Phase 1]

View source ↗

Summary

A Phase 1 study from Johns Hopkins University is evaluating single dosing with two F/TAF tablets in healthy volunteers for HIV prevention. The trial is currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Descovy (emtricitabine/tenofovir alafenamide)

Snippet

Sponsor: Johns Hopkins University | Conditions: Healthy Volunteer, HIV Prevention | Phase 1 | Status: RECRUITING